| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-05-05 |
复牌提示：
2021-05-04 19:50:01 停牌，复牌日期 2021-05-06 00:00:01
|
| 2021-05-05 |
详情>>
内部人交易：
Tovey Christopher J.等共交易11笔
|
| 2021-05-03 |
详情>>
股本变动：
变动后总股本3154.47万股
|
| 2021-05-03 |
详情>>
业绩披露：
2021年一季报每股收益-0.05美元,归母净利润-1967.7万美元,同比去年增长-147.04%
|
| 2021-03-15 |
股东大会：
将于2021-04-23召开股东大会
会议内容 ▼▲
- 1.THAT, for the purpose of giving effect to the scheme of arrangement dated March 15, 2021 between GW and the holders of Scheme Shares (as defined in such scheme of arrangement), a print of which has been produced to this meeting and for the purposes of identification signed by the Chair of this meeting, in its original form or with or subject to any modification, addition, or condition as may be agreed from time to time (including, for the avoidance of doubt, after the date of this resolution) between the Company, Jazz Pharmaceuticals UK Holdings Limited (“Bidco”) and Jazz Pharmaceuticals Public Limited Company (“Jazz”) and which (if required) is approved by the High Court of Justice of England and Wales (the “Court”), or which is otherwise imposed by the Court and is mutually acceptable to the Company, Bidco and Jazz each acting reasonably and in good faith (the “Scheme”):
1.1.the directors of GW (or a duly authorized committee of the directors) be and are hereby authorized to take all such action as they may consider necessary or appropriate for carrying the Scheme into effect;
1.2.with effect from the passing of this resolution, the articles of association of GW be and are hereby amended by the adoption and inclusion of the following new article 45:
2.THAT, the compensation that may be paid or become payable to GW’s named executive officers in connection with the Transaction, as disclosed in the table entitled “Potential Payments to Named Executive Officers” beginning on page 92 of the accompanying proxy statement, including the associated narrative discussion, and the agreements or understandings pursuant to which such compensation may be paid or become payable, are hereby approved.
|
| 2021-02-26 |
详情>>
业绩披露：
2020年年报每股收益-0.15美元,归母净利润-5812.8万美元,同比去年增长-544.51%
|
| 2020-11-05 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-0.08美元,归母净利润-2898.1万美元,同比去年增长-281.96%
|
| 2020-11-03 |
财报披露：
美东时间 2020-11-03 盘前发布财报
|
| 2020-08-07 |
详情>>
业绩披露：
2020年中报每股收益-0.04美元,归母净利润-1679.3万美元,同比去年增长-156.57%
|
| 2020-05-11 |
详情>>
业绩披露：
2020年一季报每股收益-0.02美元,归母净利润-796.5万美元,同比去年增长84.09%
|
| 2020-04-07 |
股东大会：
将于2020-05-26召开股东大会
会议内容 ▼▲
- 1.To re-elect as a director, Dr. Geoffrey Guy, who retires by rotation in accordance with the Articles of Association.
2.To re-elect as a director, Cabot Brown, who retires by rotation in accordance with the Articles of Association.
3.To approve the 2020 Long-Term Incentive Plan.
4.To receive and approve the directors’ remuneration report (excluding the directors’ remuneration policy included on pages 30 to 33 of the directors’ remuneration report) as set out on pages 16 to 35 of the Directors’ and Auditors’ Reports and the Statement of Accounts for the 12-month period ended December 31, 2019 (the “2019 U.K. Annual Report”).
5.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy statement under the “Compensation Discussion and Analysis” section, the compensation tables and the narrative disclosures that accompany the compensation tables, for the 12-month period ended December 31, 2019.
6.To ratify the Audit Committee’s appointment of Deloitte & Touche LLP as the Company’s U.S. independent registered public accounting firm for the fiscal year ending December 31, 2020.
7.To re-appoint Deloitte LLP as the Company’s U.K. statutory auditors under the U.K. Companies Act 2006, to hold office until the conclusion of the next annual general meeting of shareholders.
8.To authorize the Audit Committee to determine remuneration of the Company’s auditors for the fiscal year ending December 31, 2020.
9.To receive and adopt the 2019 U.K. Annual Report and to note that the directors do not recommend the payment of any dividend for the 12-month period ended December 31, 2019.
10.To authorize the directors, generally and unconditionally for the purpose of s551 of the U.K. Companies Act 2006 to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company (“Rights”) up to a maximum aggregate nominal amount of ￡122,950, being approximately 33% of the Company’s issued ordinary share capital at March 31, 2020, to such persons at such times and upon such conditions as the directors may determine (subject to the Company’s articles of association). This authority shall expire on the earlier of May 26, 2021 and the conclusion of the annual general meeting of the Company to be held in 2021.
11.Subject to the passing of Resolution 10, to empower the directors generally pursuant to s570(1) of the U.K. Companies Act 2006 to allot equity securities (as defined in s560 of the U.K. Companies Act 2006) for cash pursuant to the general authority conferred on them by Resolution 10 as if s561(1) of the U.K. Companies Act 2006 did not apply to that allotment. This power:
(a) shall be limited to the allotment of equity securities for cash up to a maximum aggregate nominal value of ￡37,260, being approximately 10% of the Company’s issued ordinary share capital at March 31, 2020;
(b) expires at the same time as the authority conferred by Resolution 10, but so that the Company may, before this power expires, make an offer or agreement which would or might require equity securities to be allotted or rights to be granted after it expires and the directors may allot equity securities in pursuance of such offer or agreement as if this power had not expired
(c) applies in relation to a sale of shares which is an allotment of equity securities by virtue of s560(3) of the U.K. Companies Act 2006 as if in the first paragraph of this resolution the words “pursuant to the general authority conferred on them by Resolution 10” were omitted.
|
| 2020-02-27 |
详情>>
业绩披露：
2019年年报每股收益-0.02美元,归母净利润-901.9万美元,同比去年增长96.94%
|
| 2019-08-07 |
详情>>
业绩披露：
2019年中报每股收益0.08美元,归母净利润2968.40万美元,同比去年增长119.34%
|
| 2019-05-08 |
详情>>
业绩披露：
2019年一季报每股收益-0.14美元,归母净利润-5006.4万美元,同比去年增长27.93%
|
| 2019-04-29 |
股东大会：
将于2019-06-13召开股东大会
会议内容 ▼▲
- 1.To re-elect as a director, James Noble, who retires by rotation in accordance with the Articles of Association.
2.To re-elect as a director, Thomas Lynch, who retires by rotation in accordance with the Articles of Association.
3.To receive and approve the directors’ remuneration report (excluding the directors’ remuneration policy included on pages 27 to 31 of the directors’ remuneration report) as set out on pages 15 to 33 of the Directors’ and Auditors’ Reports and the Statement of Accounts for the 15-month period ended December 31, 2018 (the “2018 U.K. Annual Report”) and also set forth as Annex A to the attached proxy statement.
4.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy statement under the “Compensation Discussion and Analysis section, the compensation tables and the narrative disclosures that accompany the compensation tables, for the 15-month period ended December 31, 2018.
5.To approve the directors’ remuneration policy on pages 27 to 31 of the 2018 U.K. Annual Report, which will take effect immediately after the AGM.
6.To determine, on a non-binding, advisory basis, that the preferred frequency of future shareholder advisory votes on the compensation of the Company’s named executive officers as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the compensation tables, and the other related disclosure, is one year.
7.To ratify the Audit Committee’s appointment of Deloitte & Touche LLP as the Company’s U.S. independent registered public accounting firm for the fiscal year ending December 31, 2019.
8.To re-appoint Deloitte LLP as the Company’s U.K. statutory auditors under the U.K. Companies Act 2006, to hold office until the conclusion of the next annual general meeting of shareholders.
9.To authorize the Audit Committee to determine remuneration of the Company’s auditors for the fiscal year ending December 31, 2019.
10.To receive, consider and adopt the 2018 U.K. Annual Report and to note that the directors do not recommend the payment of any dividend for the 15-month period ended December 31, 2018.
11.To authorize the directors, generally and unconditionally for the purpose of s551 of the U.K. Companies Act 2006 to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company (“Rights”) up to a maximum aggregate nominal amount of ￡123,000, being approximately 33% of the Company’s issued ordinary share capital at April 15, 2019, to such persons at such times and upon such conditions as the directors may determine (subject to the Company’s articles of association). This authority shall expire on the earlier of June 13, 2020 and the conclusion of the annual general meeting of the Company to be held in 2020.
|
| 2019-02-28 |
详情>>
业绩披露：
2017年年报每股收益-0.56美元,归母净利润-1.7亿美元,同比去年增长-85.9%
|
| 2019-02-28 |
详情>>
业绩披露：
2018年年报每股收益-0.88美元,归母净利润-2.95亿美元,同比去年增长-73.16%
|
| 2018-02-14 |
股东大会：
将于2018-03-14召开股东大会
会议内容 ▼▲
- 1.To receive, consider and adopt the Directors’ and Auditors’ Reports and the Statement of Accounts for the year ended 30 September 2017 (the “Annual Report”) and to note that the Directors do not recommend the payment of any dividend for the year ended on that date.
2.To approve the Directors’ Remuneration Report on pages 12 to 31 of the Annual Report, excluding the Directors’ Remuneration Policy on pages 24 to 30 which is subject to Resolution 3.
3.To approve the Directors’ Remuneration Policy on pages 24 to 30 of the Annual Report, which will take effect immediately after the Annual General Meeting of the Company on 14 March 2018.
4.To re-elect as a Director Justin Gover who retires by rotation in accordance with the articles of association of the Company.
5.To elect as a Director Catherine Mackey who, having been appointed by the Directors since the last annual general meeting of the Company on 14 March 2017, is retiring in accordance with the Articles of Association of the Company and offering herself for election.
6.To elect as a Director Alicia Secor who, having been appointed by the Directors since the last annual general meeting of the Company on 14 March 2017, is retiring in accordance with the Articles of Association of the Company and offering herself for election.
7.To elect as a Director William Waldegrave who, having been appointed by the Directors since the last annual general meeting of the Company on 14 March 2017, is retiring in accordance with the Articles of Association of the Company and offering himself for election.
8.To re-appoint Deloitte LLP as Auditors of the Company.
9.To authorise the Directors to determine the Auditors’ remuneration.
|
| 2017-02-13 |
股东大会：
将于2017-03-14召开股东大会
会议内容 ▼▲
- (1)To receive, consider and adopt the Directors’ and Auditors’ Reports and the Statement of Accounts for the year ended 30 September 2016 (the “Annual Report”) and to note that the Directors do not recommend the payment of any dividend for the year ended on that date.
(2)To approve the Directors’ Remuneration Report on pages 12 to 31 of the Annual Report.
(3)To re-elect as a Director Geoffrey Guy who retires by rotation in accordance with the articles of association of the Company.
(4)To re-elect as a Director Thomas Lynch who retires by rotation in accordance with the articles of association of the Company.
(5)To re-elect as a Director Cabot Brown who retires by rotation in accordance with the articles of association of the Company.
(6)To re-appoint Deloitte LLP as Auditors of the Company.
(7)To authorise the Directors to determine the Auditors’ remuneration.
|